 Vancouver, British Columbia--Newsfile Corp. - February 24, 2020 - FSD Pharma Inc. NASDAQ: HUGE CSE: HUGE FSE: 0K9A, a specialty, biotech pharmaceutical RD; company focused on developing, over time, a robust pipeline of FDA approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract and the musculoskeletal system, has sold its 12 equity interest in ... 